New depression drug passes first safety check in healthy volunteers
NCT ID NCT04981561
First seen Mar 25, 2026 · Last updated May 20, 2026 · Updated 14 times
Summary
This early-stage study tested a single dose of the experimental drug AGN-241751 (zelquistinel) in 68 healthy adults to see if it is safe and how the body processes it. The main goal was to check for side effects, and the study also measured drug levels in the blood. This trial did not treat depression directly but gathered important safety information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.